Mounjaro (Tirzepatide) is an advanced injectable weight loss solution now available at Influennz Clinic. If you are searching for Mounjaro weight loss treatment in Delhi, our dermatologist-led approach ensures medically supervised, safe, and personalised fat-loss management. With its dual-action mechanism, Mounjaro supports greater weight reduction compared to older medications such as Ozempic, making it a modern option for patients struggling with stubborn weight despite diet and lifestyle efforts.
Mounjaro activates both GLP-1 and GIP receptors, suppressing appetite, improving insulin function, and enhancing metabolism. This results in faster, deeper fat loss.
Book An Appointment
Mounjaro is the brand name for tirzepatide, a prescription injectable medicine developed by Eli Lilly. What makes it different from older weight-loss injections is that it works on two gut hormones at once — GLP-1 and GIP — instead of just one.
This dual action is why doctors and patients are seeing faster, more noticeable fat loss compared to single-hormone medicines like Ozempic.
In simple terms, here is what Mounjaro does inside your body:
Signals your brain so you naturally eat smaller portions without feeling deprived.
Slows down stomach emptying, keeping you feeling full for much longer.
Enhances how your body responds to insulin, processing energy more effectively.
Helps regulate blood sugar levels, working hand in hand with fat loss.
Mounjaro (tirzepatide) has been approved in India by the Central Drugs Standard Control Organisation (CDSCO) for specific medical indications. Its approved uses and prescribing recommendations may be updated over time. Therefore, treatment decisions should be made under the guidance of a qualified healthcare professional, who can provide the most current information and determine whether Mounjaro is appropriate for an individual patient.
Your weight loss treatment with Mounjaro (Tirzepatide) injections at Influennz Clinic is led by Dr. Geetika Srivastava — MD (AIIMS, Delhi), Dermatologist with 10+ years of experience, known for her personalized, medically supervised approach. Patients seeking a trusted Mounjaro doctor in Delhi rely on her expertise for safe, metabolism-focused protocols designed for sustainable fat loss rather than short-term fixes.
Mounjaro is not meant for everyone who wants to lose a few kilos — it is a medical treatment for people with a genuine weight or metabolic concern. Based on clinical guidelines, you may be a suitable candidate if you:
Mounjaro is not suitable for everyone. Before starting treatment, Dr. Geetika Srivastava screens every patient for the following, in line with standard prescribing guidelines:
This is why a proper medical consultation — not a self-prescribed online order — is essential before starting Mounjaro.
Mounjaro (Tirzepatide) follows a similar weekly weight loss injection schedule, but some users report faster fat loss due to its dual action (GLP-1 + GIP receptor agonist).
Usually 3 to 6 months or longer, but tailored per individual.
Starts low (2.5mg/week) and is gradually increased.
Noticeable changes are typically seen within 6 to 10 weeks.
Mounjaro is always started at a low dose and increased gradually. This step-up approach significantly reduces side effects like nausea.
Starting dose; body adjusts; mild appetite reduction begins.
First dose increases; fullness and reduced cravings become more noticeable.
Visible weight loss typically becomes apparent for most patients.
Maintenance/optimisation phase, adjusted to your individual response and goals.
Note: Doses above are general clinical guidelines. Dr. Geetika Srivastava personalises every patient's schedule based on tolerance and response.
Mounjaro treatment plans start from ₹9,000 per injection, depending on your dosage and treatment duration. At Influennz Clinic, we offer customized programs for Mounjaro weight loss in Delhi, along with flexible plans and combination therapies such as body contouring to enhance and accelerate your results.
Mounjaro is ideal if you:
While usually well-tolerated, some may experience:
All treatments are performed under the supervision of Dr. Geetika Srivastava, ensuring the highest standards of safety and personalized medical care. As a trusted Mounjaro clinic in Delhi, Influennz provides expert assessment, dosage planning, and continuous monitoring to help patients achieve safe and effective weight loss results with confidence.
The exact results vary from person to person, but most patients follow a predictable journey of transformation. Combining medical weight loss with our targeted MShape body contouring often helps accelerate visible changes in stubborn fat areas from the very first session.
Most patients notice significantly reduced appetite and naturally better portion control.
When combined with MShape body contouring, measurable inch-loss and shape improvements often begin from the first session.
The most dramatic changes develop, with ongoing weight loss, inch loss, and notably improved body definition throughout the treatment journey.
Think of Mounjaro as a tool, not a temporary fix. The goal isn't just to lose weight—it's to maintain a healthier weight long term. Once you reach your target, work with your doctor to create a personalized maintenance strategy rather than stopping the medication abruptly.
A careful maintenance phase instead of abruptly stopping treatment.
Lifestyle support to help your body adapt and hold its new results.
Guidance on exercise and strength training to optimize body composition.
Focus on sleep and stress management to prevent hormonal changes.
Tracking weight trends over time and adjusting your long-term plan.
A clear conversation about if and when to safely taper off.
In head-to-head clinical research, Mounjaro (tirzepatide) has outperformed Ozempic's active ingredient (semaglutide) for weight loss. A 2026 trial comparing the two directly found Mounjaro patients lost an average of 20.2% of body weight versus 13.7% with Ozempic over the same 72-week period — about 47% greater weight loss. This is because Mounjaro acts on two appetite-and-metabolism hormones (GLP-1 and GIP) instead of just one. That said, “better” depends on your individual health profile, side-effect tolerance, and medical history, which is why this decision should be made with your doctor rather than based on trial averages alone.
For most people, yes — at least partially, unless stopping is planned carefully. Clinical trial data (SURMOUNT-4) found that patients who stopped tirzepatide after significant weight loss regained 25% or more of that weight within a year, on average. This happens because obesity involves long-term changes in appetite-regulating hormones, and those hormones tend to return to their previous patterns once the medication is stopped. This is why doctors generally recommend a structured maintenance plan — with nutrition support and possible dose tapering — rather than stopping abruptly.
Mounjaro is not suitable for everyone. You should not take it if you have a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), a known allergy to tirzepatide, or if you are pregnant, breastfeeding, or planning a pregnancy. It's also not approved for type 1 diabetes and requires careful evaluation if you have a history of pancreatitis or significant digestive disorders. A detailed medical screening before starting treatment is essential to rule out these and other risk factors.
You can, but it's important to plan this with your doctor rather than stopping on your own once you hit a target weight. Because obesity is considered a chronic condition, clinical research shows that stopping treatment abruptly often leads to significant weight regain within a year. A more sustainable approach is a doctor-guided maintenance phase — which may include continuing at a lower maintenance dose, gradual tapering, and strong nutrition and lifestyle support — to help you hold on to your results long-term.